Duncan E. Crombie

Duncan E. Crombie

Auto-generated profile, based on publicly available information

Duncan E. Crombie

Monash University, Clayton, Victoria, Australia

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 December 2015 in Stem Cells International
Verified
Journal Article
Open access
PDF file
DHDamián Hernández
Damián Hernández
RMRodney Millard
Rodney Millard
PSPriyadharshini Sivakumaran
Priyadharshini Sivakumaran
Raymond C. B. WongRaymond C. B. Wong
Raymond C. B. Wong
DCDuncan E Crombie
Duncan E Crombie
SLShiang Yong Lim
Shiang Yong Lim
Background. Human induced pluripotent stem cells (iPSCs) are an attractive source of cardiomyocytes for cardiac repair and regeneration. In this study, we aim to determine whether acute electrical stimulation of human iPSCs can promote their differentiation to cardiomyocytes. Methods. Human iPSCs were differentiated to cardiac cells by forming embryoid bodies (EBs) for 5 days. EBs were then subjected to brief electrical stimulation and plated down for 14 days. Results. In iPS(Foreskin)‐2 cell line, brief electrical stimulation at 65 mV/mm or 200 mV/mm for 5 min significantly increased the percentage of beating EBs present by day 14 after plating. Acute electrical stimulation also significantly increased the cardiac gene expression of ACTC1, TNNT2, MYH7, and MYL7. However, the cardiogenic effect of electrical stimulation was not reproducible in another iPS cell line, CERA007c6. Beating EBs from control and electrically stimulated groups expressed various cardiac‐specific transcription factors and contractile muscle markers. Beating EBs were also shown to cycle calcium and were responsive to the chronotropic agents, isoproterenol and carbamylcholine, in a concentration‐dependent manner. Conclusions. Our results demonstrate that brief electrical stimulation can promote cardiac differentiation of human iPS cells. The cardiogenic effect of brief electrical stimulation is dependent on the cell line used.

22 December 2010 in Stem Cell Reviews and Reports
Verified
Journal Article
Closed access
PDF file
Jun-Ping LiuJun-Ping Liu
Jun-Ping Liu
PVPaul J. Verma
Paul J. Verma
MEMarguerite V. Evans-Galea
Marguerite V. Evans-Galea
MDMartin B. Delatycki
Martin B. Delatycki
AMAnna Michalska
Anna Michalska
APAlice Pébay
Alice Pébay

1 September 2012 in The American Journal of Pathology
Verified
Journal Article
Open access
YGYona Goldshmit
Yona Goldshmit
RMRosalia Matteo
Rosalia Matteo
Tamar SztalTamar Sztal
Tamar Sztal
FEFelix Ellett
Felix Ellett
FFFrisca Frisca
Frisca Frisca
APAlice Pébay
Alice Pébay
Evidence suggests a proinflammatory role of lysophosphatidic acid (LPA) in various pathologic abnormalities, including in the central nervous system. Herein, we describe LPA as an important mediator of inflammation after spinal cord injury (SCI) in zebrafish and mice. Furthermore, we describe a novel monoclonal blocking antibody raised against LPA that potently inhibits LPA's effect in vitro and in vivo. This antibody, B3, specifically binds LPA, prevents it from interacting with its complement of receptors, and blocks LPA's effects on the neuronal differentiation of human neural stem/progenitor cells, demonstrating its specificity toward LPA signaling. When administered systemically to mice subjected to SCI, B3 substantially reduced glial inflammation and neuronal death. B3-treated animals demonstrated significantly more neuronal survival upstream of the lesion site, with some functional improvement. This study describes the use of anti-LPA monoclonal antibody as a novel therapeutic approach for the treatment of SCI.

24 July 2013 in Stem Cells Translational Medicine
Verified
Journal Article
Open access
PDF file
SLShiang Yong Lim
Shiang Yong Lim
PSPriyadharshini Sivakumaran
Priyadharshini Sivakumaran
DCDuncan E. Crombie
Duncan E. Crombie
GDGregory J. Dusting
Gregory J. Dusting
APAlice Pébay
Alice Pébay
RDRodney J. Dilley
Rodney J. Dilley
Human induced pluripotent stem (iPS) cells are a promising source of autologous cardiomyocytes to repair and regenerate myocardium for treatment of heart disease. In this study, we have identified a novel strategy to enhance cardiac differentiation of human iPS cells by treating embryoid bodies (EBs) with a histone deacetylase inhibitor, trichostatin A (TSA), together with activin A and bone morphogenetic protein 4 (BMP4). Over a narrow window of concentrations, TSA (1 ng/ml) directed the differentiation of human iPS cells into a cardiomyocyte lineage. TSA also exerted an additive effect with activin A (100 ng/ml) and BMP4 (20 ng/ml). The resulting cardiomyocytes expressed several cardiac-specific transcription factors and contractile proteins at both gene and protein levels. Functionally, the contractile EBs displayed calcium cycling and were responsive to the chronotropic agents isoprenaline (0.1 μM) and carbachol (1 μM). Implanting microdissected beating areas of iPS cells into tissue engineering chambers in immunocompromised rats produced engineered constructs that supported their survival, and they maintained spontaneous contraction. Human cardiomyocytes were identified as compact patches of muscle tissue incorporated within a host fibrocellular stroma and were vascularized by host neovessels. In conclusion, human iPS cell-derived cardiomyocytes can be used to engineer functional cardiac muscle tissue for studying the pathophysiology of cardiac disease, for drug discovery test beds, and potentially for generation of cardiac grafts to surgically replace damaged myocardium.

15 January 2011 in Cellular and Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
TFTony Frugier
Tony Frugier
DCDuncan Crombie
Duncan Crombie
ACAlison Conquest
Alison Conquest
FTFrisca Tjhong
Frisca Tjhong
CTCaroline Taylor
Caroline Taylor
APAlice Pébay
Alice Pébay

1 May 2013 in Journal of Lipid Research
Verified
Journal Article
Open access
PDF file
FFFrisca Frisca
Frisca Frisca
DCDuncan E. Crombie
Duncan E. Crombie
MDMirella Dottori
Mirella Dottori
YGYona Goldshmit
Yona Goldshmit
APAlice Pébay
Alice Pébay
We previously reported that lysophosphatidic acid (LPA) inhibits the neuronal differentiation of human embryonic stem cells (hESC). We extended these studies by analyzing LPA's effects on the expansion of neural stem/progenitor cells (NS/PC) derived from hESCs and human induced pluripotent stem cells (iPSC), and we assessed whether data obtained on the neural differentiation of hESCs were relevant to iPSCs. We showed that hESCs and iPSCs exhibited comparable mRNA expression profiles of LPA receptors and producing enzymes upon neural differentiation. We demonstrated that LPA inhibited the expansion of NS/PCs of both origins, mainly by increased apoptosis in a Rho/Rho-associated kinase (ROCK)-dependent mechanism. Furthermore, LPA inhibited the neuronal differentiation of iPSCs. Lastly, LPA induced neurite retraction of NS/PC-derived early neurons through Rho/ROCK, which was accompanied by myosin light chain (MLC) phosphorylation. Our data demonstrate the consistency of LPA effects across various sources of human NS/PCs, rendering hESCs and iPSCs valuable models for studying lysophospholipid signaling in human neural cells. Our data also highlight the importance of the Rho/ROCK pathway in human NS/PCs. As LPA levels are increased in the central nervous system (CNS) following injury, LPA-mediated effects on NS/PCs and early neurons could contribute to the poor neurogenesis observed in the CNS following injury.